Skip to main content

Table 1 Baseline characteristics of all HCC patients

From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

Characteristics

Value

Patients

616

Pre-TACE

145 (23.5)

Age (yrs.)

56.0 (18.0)

Male

556 (90.3)

Ablation

 Radiofrequency

469 (76.1)

 Microwave

147 (23.9)

Tumor number

 Single

499 (81.0)

 Multiple

117 (19.0)

Tumor size (cm)

 ≤ 3

473 (76.8)

 > 3

143 (23.2)

Risk area

159 (25.8)

AFP ≥200 ng/ml

187 (30.4)

Hb (109/L)

142.0 (22.3)

PLT (109/L)

121.0 (90.0)

RBC (109/L)

4.6 (0.8)

WBC (109/L)

5.2 (2.5)

ALB (g/L)

41.5 (6.0)

ALT (U/L)

35.2 (26.8)

AST (U/L)

33.6 22.57)

TBIL (μmol/L)

15.0 (20.4)

Child-Pugh grade

 A

594 (96.4)

 B

22 (3.6)

PT (seconds)

12.3 (1.8)

Viral hepatitis

574 (93.2)

Cirrhosis

503 (81.7)

  1. Abbreviations: TACE Transcatheter arterial chemoembolization, AFP alpha-fetoprotein, Hb Hemoglobin, PLT platelet, RBC red blood cell, WBC white blood cell, ALB albumin, ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, PT prothrombin time
  2. Values are presented as the median (IQR) or n (%)